Senior insider sale
Chief Strategy Officer at JANUX THERAPEUTICS, INC. — senior position signals high conviction
$2.12M
129.79K shares
What this filing means
ROBINSON BYRON plans to sell 129.79K shares of JANUX THERAPEUTICS, INC. valued at approximately $2.12M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/15/2025ACC: 0001950047-25-010281
Officer· Chief Strategy Officer
Since Mar 2022
129.79K
Shares to sell
$2.12M
Approx. market value
16.67K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
12/15/2025
16.67KTotal acquired16.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/15/2025 | Stock Option Exercise Cash | 16.67K | — |
| Total | 16.67K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
50K
Market value
$826.0K
12/8/2025
—Completed
Units to sell
63.13K
Market value
$1.03M
12/2/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.67K
Market value
$258.4K
12/15/2025
Total
Units
129.79K
Value
$2.12M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/8/2025 | 50K | $826.0K | — | Completed |
12/2/2025 | 63.13K | $1.03M | — | Completed |
| Planned — Approximate Date | ||||
12/15/2025 | 16.67K | $258.4K | NASDAQ | Planned |
| Total | 129.79K | $2.12M | ||